PRJNA866322
Development and Validation of Differential Diagnostic Models for Immunoglobulin A Nephropathy (IgAN) Based on Gut Microbes and Serum Metabolomic Studies
Background: Immunoglobulin A nephropathy (IgAN) is a prevalent primary glomerular disease. The differential diagnostic potential of gut microbiome for IgAN and relationship of gut microbiota, serum metabolites, and clinical phenotypes in patients with IgAN and have not been well evaluated.